The Saturday Refill and the Expired Therapeutic Contact Lens Prescription
Dr. Alvarez is the covering optometrist on a Saturday at a group practice in Birmingham. A patient presents with a red, painful right eye. She wears a bandage soft contact lens that was prescribed 14 months ago by a different OD in the practice for recurrent corneal erosion; the original prescription and fitting records are in the chart. The patient reports the lens has been in place continuously for 9 days and that she ran out of her prophylactic topical antibiotic two days ago. Slit lamp shows a 3 mm corneal epithelial defect with mild infiltrate and 2+ cells in the anterior chamber. Dr. Alvarez wants to remove the lens, start a fluoroquinolone q2h, and dispense a new bandage lens today so the patient does not have to return Monday. The practice's therapeutic contact lens agreement and the state's pharmaceutical and scope rules are in play.
1. Can Dr. Alvarez dispense a replacement bandage contact lens today under the existing 14-month-old prescription? What must she document and verify?
Read the worked answer
No. A therapeutic contact lens is a prescription device, and a 14-month-old prescription is outside the typical one-year renewal window used for contact lens prescriptions; the optometrist must conduct a new fitting/evaluation and issue a new prescription before dispensing. Practically, Dr. Alvarez should: (1) perform and document a new anterior segment evaluation, including the epithelial defect size, infiltrate, and AC reaction; (2) confirm the lens parameters and base curve appropriate for the current cornea, not simply reuse the old lens; (3) write a new prescription and record the medical necessity (bandage indication) in the chart; (4) verify the practice's therapeutic lens agreement/consent is current and have the patient sign an updated one if needed. The clinical urgency supports same-day dispensing, but urgency does not substitute for a valid current prescription.
2. The patient has run out of her antibiotic and Dr. Alvarez wants to start a fluoroquinolone. What pharmaceutical authority and documentation issues apply, and how should the plan be communicated?
Read the worked answer
Assuming Dr. Alvarez holds current Alabama therapeutic pharmaceutical authority (TPA) certification, she may prescribe the topical fluoroquinolone. Key points: confirm her license and TPA certification are active and that the drug is within the formulary/scope she is authorized to prescribe; document the diagnosis (corneal defect with infiltrate), the drug, concentration, dosing (q2h while awake), duration, and rationale; counsel the patient on administration, contact lens handling, and red-flag symptoms (worsening pain, vision loss, discharge) with instructions to return or seek urgent care. If the infiltrate suggests microbial keratitis beyond her comfort or scope, arrange ophthalmology co-management. The prescription should be transmitted and recorded consistent with the practice's prescription monitoring and recordkeeping policies.
3. What follow-up and referral obligations does Dr. Alvarez have, and what would make this a reportable standard-of-care problem?
Read the worked answer
She should schedule a recheck within 24–48 hours (not wait until the next routine visit), document the plan for lens removal and re-evaluation, and give explicit return precautions. Referral to ophthalmology is indicated if the infiltrate does not improve, if there is significant stromal involvement, hypopyon, or worsening vision. The case becomes a potential standard-of-care/disciplinary issue if the record shows: dispensing a device on an expired prescription without a new evaluation; failure to document the anterior segment findings and medical necessity; prescribing outside TPA scope; or failing to provide adequate follow-up for a potentially vision-threatening condition. Good documentation of the clinical reasoning and the follow-up plan is the best protection.